HENRY J. FUCHS - 15 Mar 2024 Form 4 Insider Report for BIOMARIN PHARMACEUTICAL INC (BMRN)

Role
President, Worldwide R&D
Signature
/s/ Tae Sang Yoo, Attorney-in-Fact
Issuer symbol
BMRN
Transactions as of
15 Mar 2024
Transactions value $
-$2,808,387
Form type
4
Filing time
19 Mar 2024, 20:46:14 UTC
Previous filing
07 Mar 2024
Next filing
17 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BMRN Common Stock Award $0 +18.2K +8.6% $0.00 230K 15 Mar 2024 Direct F1
transaction BMRN Common Stock Tax liability -$2.81M -33.5K -14.54% $83.87 197K 15 Mar 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BMRN Stock Option (Right to Buy Common Stock) Award $0 +40.9K $0.00 40.9K 15 Mar 2024 Common Stock 40.9K $83.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units granted March 15, 2024. Price not applicable.
F2 Option grant vests 12/48th on March 15, 2025 and 1/48th on the 15th day of each month thereafter.